Home › Companies › Integra LifeSciences Holdings Corporation › 2025-2026
Download data (CSV): ballot items · votes by manager · column guide.
Compiled from SEC Form N-PX filings and Integra LifeSciences Holdings Corporation’s Form 8-K, filed May 8, 2026 (Item 5.07 on EDGAR). Page generated November 20, 2026.
Meeting of May 7, 2026: 10 items on Integra LifeSciences Holdings Corporation’s Form 8-K, filed May 8, 2026: 7 elected · 3 approved.
Notable dissent: 1 director (10.2% against).
Dissent tiers, on the company’s own Form 8-K tally (support = FOR ÷ (FOR + AGAINST), or FOR ÷ (FOR + WITHHELD) on a withhold ballot; abstentions and broker non-votes excluded): shareholder proposals with 15% support or more are notable, 25% significant, 40% high; director nominees with 10% or more against or withheld are notable, 20% significant; say-on-pay under 80% support is notable, under 70% significant; equity and compensation plans with 15% or more against are notable, 25% significant; any other item the board put forward with 15% or more against is notable. How this is decided
Proxy season: 2023-2024 2024-2025 2025-2026
Activist investors: Rubric Capital (13F, 9.5%, as of September 30, 2026)
Explore Integra LifeSciences Holdings Corporation in the interactive database Compare manager voting policies
These tallies are Integra LifeSciences Holdings Corporation’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed May 8, 2026 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Keith Bradley, Ph.D. | 64,904,372 | 4,378,288 | 33,540 | -- | 3,918,311 | 94% | Elected | — |
| Elect Director: Shaundra D. Clay | 68,996,420 | 286,939 | 32,841 | -- | 3,918,311 | 99.6% | Elected | — |
| Elect Director: Stuart M. Essig, Ph.D. | 68,172,670 | 1,113,688 | 29,842 | -- | 3,918,311 | 98% | Elected | — |
| Elect Director: Jeffrey A. Graves, Ph.D. | 65,841,917 | 3,442,844 | 31,439 | -- | 3,918,311 | 95% | Elected | — |
| Elect Director: Barbara B. Hill | 62,241,203 | 7,042,475 | 32,522 | -- | 3,918,311 | 90% | Elected | — |
| Elect Director: Renee W. Lo | 68,619,639 | 664,390 | 32,171 | -- | 3,918,311 | 99.0% | Elected | — |
| Elect Director: Christian S. Schade | 68,247,357 | 1,037,010 | 31,833 | -- | 3,918,311 | 99% | Elected | — |
| 2. The appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the 2026 fiscal year | 72,313,820 | 863,179 | 57,512 | -- | 0 | 99% | Approved | — |
| 3. On an advisory, non-binding basis, the compensation of the Company's named executive officers | 68,472,769 | 732,580 | 110,851 | -- | 3,918,311 | 99% | Approved | — |
| 4. The Plan Amendment | 68,005,433 | 1,269,231 | 41,536 | -- | 3,918,311 | 98% | Approved | — |
Source: Integra LifeSciences Holdings Corporation, Form 8-K, filed with the SEC on May 8, 2026 — read the filing on EDGAR.
See voting trends for Health Care companies, 2025-2026: shareholder support by sector and by company size.
256 asset managers disclosed a vote on at least one Integra LifeSciences Holdings Corporation item in their SEC Form N-PX filings. Each item below shows how many of them voted on it, and how. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of Integra LifeSciences Holdings Corporation’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.
Combines 5 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
Prior year: 98.0% for (May 9, 2025 meeting) ▲ 0.4 pts
Description as filed by funds: To elect eight directors of the Company to serve until the next annual meeting of stockholders and until their successors are duly elected and qualified: Stuart M. Essig
Integra LifeSciences Holdings Corporation’s own tally for this item (“Elect Director: Stuart M. Essig, Ph.D.”): 68,172,670 for, 1,113,688 against, per its Form 8-K filed May 8, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “The final results of the matters submitted to a vote of stockholders at the Annual Meeting are as follows: Item No. 1: All of the nominees for director of the Board of Directors (the "Board") of the Company were elected to serve until the Company's 2027 Annual Meeting of Stockholders and until thei…”
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 74 asset managers below reported 31,509,261 for, 139,021 against, 20,489 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 7,098,002 | 0 | 0 | 0 | For |
| Vanguard | 7,018,387 | 9,193 | 0 | 0 | For |
| Invesco | 3,477,634 | 0 | 0 | 0 | For |
| UNDISCOVERED MANAGERS FUNDS | 2,890,843 | 0 | 0 | 0 | For |
| Charles Schwab | 1,518,669 | 0 | 0 | 0 | For |
| Fidelity | 1,276,394 | 0 | 0 | 0 | For |
| Dimensional | 1,080,614 | 0 | 0 | 0 | For |
| State Street | 993,275 | 57 | 1,159 | 0 | For |
| GLENMEDE FUND INC | 890,722 | 0 | 0 | 0 | For |
| PARADIGM FUNDS | 710,000 | 0 | 0 | 0 | For |
| PIMCO | 619,001 | 0 | 0 | 0 | For |
| Neuberger Berman | 560,108 | 0 | 0 | 0 | For |
| Hartford | 271,216 | 0 | 0 | 0 | For |
| Victory Capital | 196,094 | 0 | 0 | 0 | For |
| Goldman Sachs | 192,355 | 0 | 0 | 0 | For |
| TRUST FOR PROFESSIONAL MANAGERS | 173,498 | 0 | 0 | 0 | For |
| TIAA | 153,428 | 0 | 0 | 0 | For |
| Equitable | 152,503 | 0 | 0 | 0 | For |
| Jackson National | 135,152 | 0 | 0 | 0 | For |
| Transamerica | 134,600 | 0 | 0 | 0 | For |
| American Century | 126,080 | 0 | 0 | 0 | For |
| NYLIM VP FUNDS TRUST | 125,529 | 0 | 0 | 0 | For |
| SEI | 124,761 | 0 | 0 | 0 | For |
| Managed Portfolio Series | 124,478 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 107,580 | 0 | 0 | 0 | For |
Showing the 25 largest of 74 asset managers. All 74 are in the interactive database (link above).
Combines 5 wordings of this item as funds reported it.
95% Majority: yes · of votes cast
Prior year: 99.4% for (May 9, 2025 meeting) ▼ 4.3 pts
Description as filed by funds: To elect eight directors of the Company to serve until the next annual meeting of stockholders and until their successors are duly elected and qualified: Jeffrey A. Graves
Integra LifeSciences Holdings Corporation’s own tally for this item (“Elect Director: Jeffrey A. Graves, Ph.D.”): 65,841,917 for, 3,442,844 against, per its Form 8-K filed May 8, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “The final results of the matters submitted to a vote of stockholders at the Annual Meeting are as follows: Item No. 1: All of the nominees for director of the Board of Directors (the "Board") of the Company were elected to serve until the Company's 2027 Annual Meeting of Stockholders and until thei…”
Support: 95% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 74 asset managers below reported 31,597,614 for, 51,827 against, 19,330 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 7,098,002 | 0 | 0 | 0 | For |
| Vanguard | 7,027,565 | 14 | 0 | 0 | For |
| Invesco | 3,477,634 | 0 | 0 | 0 | For |
| UNDISCOVERED MANAGERS FUNDS | 2,890,843 | 0 | 0 | 0 | For |
| Charles Schwab | 1,518,669 | 0 | 0 | 0 | For |
| Fidelity | 1,276,394 | 0 | 0 | 0 | For |
| Dimensional | 1,080,614 | 0 | 0 | 0 | For |
| State Street | 994,492 | 0 | 0 | 0 | For |
| GLENMEDE FUND INC | 890,722 | 0 | 0 | 0 | For |
| PARADIGM FUNDS | 710,000 | 0 | 0 | 0 | For |
| PIMCO | 619,001 | 0 | 0 | 0 | For |
| Neuberger Berman | 560,108 | 0 | 0 | 0 | For |
| Hartford | 271,216 | 0 | 0 | 0 | For |
| Victory Capital | 196,094 | 0 | 0 | 0 | For |
| Goldman Sachs | 192,355 | 0 | 0 | 0 | For |
| TRUST FOR PROFESSIONAL MANAGERS | 173,498 | 0 | 0 | 0 | For |
| TIAA | 153,428 | 0 | 0 | 0 | For |
| Equitable | 152,503 | 0 | 0 | 0 | For |
| Jackson National | 135,152 | 0 | 0 | 0 | For |
| Transamerica | 134,600 | 0 | 0 | 0 | For |
| American Century | 126,080 | 0 | 0 | 0 | For |
| NYLIM VP FUNDS TRUST | 125,529 | 0 | 0 | 0 | For |
| SEI | 124,761 | 0 | 0 | 0 | For |
| Managed Portfolio Series | 124,478 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 107,580 | 0 | 0 | 0 | For |
Showing the 25 largest of 74 asset managers. All 74 are in the interactive database (link above).
Combines 5 wordings of this item as funds reported it.
90% Majority: yes · of votes cast
Prior year: 97.4% for (May 9, 2025 meeting) ▼ 7.6 pts
Description as filed by funds: To elect eight directors of the Company to serve until the next annual meeting of stockholders and until their successors are duly elected and qualified: Barbara B. Hill
Integra LifeSciences Holdings Corporation’s own tally for this item (“Elect Director: Barbara B. Hill”): 62,241,203 for, 7,042,475 against, per its Form 8-K filed May 8, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “The final results of the matters submitted to a vote of stockholders at the Annual Meeting are as follows: Item No. 1: All of the nominees for director of the Board of Directors (the "Board") of the Company were elected to serve until the Company's 2027 Annual Meeting of Stockholders and until thei…”
Support: 90% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 74 asset managers below reported 30,264,114 for, 1,384,168 against, 20,489 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 7,098,002 | 0 | 0 | 0 | For |
| Vanguard | 7,013,703 | 13,877 | 0 | 0 | For |
| Invesco | 3,477,634 | 0 | 0 | 0 | For |
| UNDISCOVERED MANAGERS FUNDS | 2,890,843 | 0 | 0 | 0 | For |
| Charles Schwab | 1,518,669 | 0 | 0 | 0 | For |
| Fidelity | 1,276,394 | 0 | 0 | 0 | For |
| Dimensional | 1,080,614 | 0 | 0 | 0 | For |
| State Street | 2,345 | 990,988 | 1,159 | 0 | Against |
| GLENMEDE FUND INC | 890,722 | 0 | 0 | 0 | For |
| PARADIGM FUNDS | 710,000 | 0 | 0 | 0 | For |
| PIMCO | 619,001 | 0 | 0 | 0 | For |
| Neuberger Berman | 560,108 | 0 | 0 | 0 | For |
| Hartford | 271,216 | 0 | 0 | 0 | For |
| Victory Capital | 196,094 | 0 | 0 | 0 | For |
| Goldman Sachs | 192,355 | 0 | 0 | 0 | For |
| TRUST FOR PROFESSIONAL MANAGERS | 173,498 | 0 | 0 | 0 | For |
| TIAA | 0 | 153,428 | 0 | 0 | Against |
| Equitable | 152,503 | 0 | 0 | 0 | For |
| Jackson National | 135,152 | 0 | 0 | 0 | For |
| Transamerica | 134,600 | 0 | 0 | 0 | For |
| American Century | 126,080 | 0 | 0 | 0 | For |
| NYLIM VP FUNDS TRUST | 125,529 | 0 | 0 | 0 | For |
| SEI | 124,761 | 0 | 0 | 0 | For |
| Managed Portfolio Series | 124,478 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 107,580 | 0 | 0 | 0 | For |
Showing the 25 largest of 74 asset managers. All 74 are in the interactive database (link above).
Combines 5 wordings of this item as funds reported it.
99.0% Majority: yes · of votes cast
Prior year: 98.9% for (May 9, 2025 meeting) ▲ 0.1 pts
Description as filed by funds: To elect eight directors of the Company to serve until the next annual meeting of stockholders and until their successors are duly elected and qualified: Renee W. Lo
Integra LifeSciences Holdings Corporation’s own tally for this item (“Elect Director: Renee W. Lo”): 68,619,639 for, 664,390 against, per its Form 8-K filed May 8, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “The final results of the matters submitted to a vote of stockholders at the Annual Meeting are as follows: Item No. 1: All of the nominees for director of the Board of Directors (the "Board") of the Company were elected to serve until the Company's 2027 Annual Meeting of Stockholders and until thei…”
Support: 99.0% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 74 asset managers below reported 31,650,070 for, 28,212 against, 20,489 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 7,098,002 | 0 | 0 | 0 | For |
| Vanguard | 7,018,388 | 9,192 | 0 | 0 | For |
| Invesco | 3,477,634 | 0 | 0 | 0 | For |
| UNDISCOVERED MANAGERS FUNDS | 2,890,843 | 0 | 0 | 0 | For |
| Charles Schwab | 1,518,669 | 0 | 0 | 0 | For |
| Fidelity | 1,276,394 | 0 | 0 | 0 | For |
| Dimensional | 1,080,614 | 0 | 0 | 0 | For |
| State Street | 993,333 | 0 | 1,159 | 0 | For |
| GLENMEDE FUND INC | 890,722 | 0 | 0 | 0 | For |
| PARADIGM FUNDS | 710,000 | 0 | 0 | 0 | For |
| PIMCO | 619,001 | 0 | 0 | 0 | For |
| Neuberger Berman | 560,108 | 0 | 0 | 0 | For |
| Hartford | 271,216 | 0 | 0 | 0 | For |
| Victory Capital | 196,094 | 0 | 0 | 0 | For |
| Goldman Sachs | 192,355 | 0 | 0 | 0 | For |
| TRUST FOR PROFESSIONAL MANAGERS | 173,498 | 0 | 0 | 0 | For |
| TIAA | 153,428 | 0 | 0 | 0 | For |
| Equitable | 152,503 | 0 | 0 | 0 | For |
| Jackson National | 135,152 | 0 | 0 | 0 | For |
| Transamerica | 134,600 | 0 | 0 | 0 | For |
| American Century | 126,080 | 0 | 0 | 0 | For |
| NYLIM VP FUNDS TRUST | 125,529 | 0 | 0 | 0 | For |
| SEI | 124,761 | 0 | 0 | 0 | For |
| Managed Portfolio Series | 124,478 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 107,580 | 0 | 0 | 0 | For |
Showing the 25 largest of 74 asset managers. All 74 are in the interactive database (link above).
Combines 5 wordings of this item as funds reported it.
99% Majority: yes · of votes cast
Prior year: 97.8% for (May 9, 2025 meeting) ▲ 0.7 pts
Description as filed by funds: To elect eight directors of the Company to serve until the next annual meeting of stockholders and until their successors are duly elected and qualified: Christian S. Schade
Integra LifeSciences Holdings Corporation’s own tally for this item (“Elect Director: Christian S. Schade”): 68,247,357 for, 1,037,010 against, per its Form 8-K filed May 8, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “The final results of the matters submitted to a vote of stockholders at the Annual Meeting are as follows: Item No. 1: All of the nominees for director of the Board of Directors (the "Board") of the Company were elected to serve until the Company's 2027 Annual Meeting of Stockholders and until thei…”
Support: 99% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 74 asset managers below reported 31,650,012 for, 28,270 against, 20,489 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 7,098,002 | 0 | 0 | 0 | For |
| Vanguard | 7,018,387 | 9,193 | 0 | 0 | For |
| Invesco | 3,477,634 | 0 | 0 | 0 | For |
| UNDISCOVERED MANAGERS FUNDS | 2,890,843 | 0 | 0 | 0 | For |
| Charles Schwab | 1,518,669 | 0 | 0 | 0 | For |
| Fidelity | 1,276,394 | 0 | 0 | 0 | For |
| Dimensional | 1,080,614 | 0 | 0 | 0 | For |
| State Street | 993,275 | 57 | 1,159 | 0 | For |
| GLENMEDE FUND INC | 890,722 | 0 | 0 | 0 | For |
| PARADIGM FUNDS | 710,000 | 0 | 0 | 0 | For |
| PIMCO | 619,001 | 0 | 0 | 0 | For |
| Neuberger Berman | 560,108 | 0 | 0 | 0 | For |
| Hartford | 271,216 | 0 | 0 | 0 | For |
| Victory Capital | 196,094 | 0 | 0 | 0 | For |
| Goldman Sachs | 192,355 | 0 | 0 | 0 | For |
| TRUST FOR PROFESSIONAL MANAGERS | 173,498 | 0 | 0 | 0 | For |
| TIAA | 153,428 | 0 | 0 | 0 | For |
| Equitable | 152,503 | 0 | 0 | 0 | For |
| Jackson National | 135,152 | 0 | 0 | 0 | For |
| Transamerica | 134,600 | 0 | 0 | 0 | For |
| American Century | 126,080 | 0 | 0 | 0 | For |
| NYLIM VP FUNDS TRUST | 125,529 | 0 | 0 | 0 | For |
| SEI | 124,761 | 0 | 0 | 0 | For |
| Managed Portfolio Series | 124,478 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 107,580 | 0 | 0 | 0 | For |
Showing the 25 largest of 74 asset managers. All 74 are in the interactive database (link above).
Combines 5 wordings of this item as funds reported it.
94% Majority: yes · of votes cast
Prior year: 97.8% for (May 9, 2025 meeting) ▼ 4.1 pts
Description as filed by funds: To elect eight directors of the Company to serve until the next annual meeting of stockholders and until their successors are duly elected and qualified: Keith Bradley
Integra LifeSciences Holdings Corporation’s own tally for this item (“Elect Director: Keith Bradley, Ph.D.”): 64,904,372 for, 4,378,288 against, per its Form 8-K filed May 8, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “The final results of the matters submitted to a vote of stockholders at the Annual Meeting are as follows: Item No. 1: All of the nominees for director of the Board of Directors (the "Board") of the Company were elected to serve until the Company's 2027 Annual Meeting of Stockholders and until thei…”
Support: 94% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 74 asset managers below reported 31,403,038 for, 185,244 against, 20,489 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 7,098,002 | 0 | 0 | 0 | For |
| Vanguard | 7,018,374 | 9,206 | 0 | 0 | For |
| Invesco | 3,477,634 | 0 | 0 | 0 | For |
| UNDISCOVERED MANAGERS FUNDS | 2,890,843 | 0 | 0 | 0 | For |
| Charles Schwab | 1,518,669 | 0 | 0 | 0 | For |
| Fidelity | 1,276,394 | 0 | 0 | 0 | For |
| Dimensional | 1,080,614 | 0 | 0 | 0 | For |
| State Street | 993,275 | 57 | 1,159 | 0 | For |
| GLENMEDE FUND INC | 890,722 | 0 | 0 | 0 | For |
| PARADIGM FUNDS | 710,000 | 0 | 0 | 0 | For |
| PIMCO | 619,001 | 0 | 0 | 0 | For |
| Neuberger Berman | 560,108 | 0 | 0 | 0 | For |
| Hartford | 271,216 | 0 | 0 | 0 | For |
| Victory Capital | 196,094 | 0 | 0 | 0 | For |
| Goldman Sachs | 192,355 | 0 | 0 | 0 | For |
| TRUST FOR PROFESSIONAL MANAGERS | 173,498 | 0 | 0 | 0 | For |
| TIAA | 153,428 | 0 | 0 | 0 | For |
| Equitable | 152,503 | 0 | 0 | 0 | For |
| Jackson National | 135,152 | 0 | 0 | 0 | For |
| Transamerica | 134,600 | 0 | 0 | 0 | For |
| American Century | 126,080 | 0 | 0 | 0 | For |
| NYLIM VP FUNDS TRUST | 125,529 | 0 | 0 | 0 | For |
| SEI | 124,761 | 0 | 0 | 0 | For |
| Managed Portfolio Series | 124,478 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 107,580 | 0 | 0 | 0 | For |
Showing the 25 largest of 74 asset managers. All 74 are in the interactive database (link above).
Combines 5 wordings of this item as funds reported it.
99.6% Majority: yes · of votes cast
Prior year: 99.7% for (May 9, 2025 meeting) ▼ 0.1 pts
Description as filed by funds: To elect eight directors of the Company to serve until the next annual meeting of stockholders and until their successors are duly elected and qualified: Shaundra D. Clay
Integra LifeSciences Holdings Corporation’s own tally for this item (“Elect Director: Shaundra D. Clay”): 68,996,420 for, 286,939 against, per its Form 8-K filed May 8, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “The final results of the matters submitted to a vote of stockholders at the Annual Meeting are as follows: Item No. 1: All of the nominees for director of the Board of Directors (the "Board") of the Company were elected to serve until the Company's 2027 Annual Meeting of Stockholders and until thei…”
Support: 99.6% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 74 asset managers below reported 31,560,071 for, 28,211 against, 20,489 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 7,098,002 | 0 | 0 | 0 | For |
| Vanguard | 7,018,389 | 9,191 | 0 | 0 | For |
| Invesco | 3,477,634 | 0 | 0 | 0 | For |
| UNDISCOVERED MANAGERS FUNDS | 2,890,843 | 0 | 0 | 0 | For |
| Charles Schwab | 1,518,669 | 0 | 0 | 0 | For |
| Fidelity | 1,276,394 | 0 | 0 | 0 | For |
| Dimensional | 1,080,614 | 0 | 0 | 0 | For |
| State Street | 993,333 | 0 | 1,159 | 0 | For |
| GLENMEDE FUND INC | 890,722 | 0 | 0 | 0 | For |
| PARADIGM FUNDS | 710,000 | 0 | 0 | 0 | For |
| PIMCO | 619,001 | 0 | 0 | 0 | For |
| Neuberger Berman | 560,108 | 0 | 0 | 0 | For |
| Hartford | 271,216 | 0 | 0 | 0 | For |
| Victory Capital | 196,094 | 0 | 0 | 0 | For |
| Goldman Sachs | 192,355 | 0 | 0 | 0 | For |
| TRUST FOR PROFESSIONAL MANAGERS | 173,498 | 0 | 0 | 0 | For |
| TIAA | 153,428 | 0 | 0 | 0 | For |
| Equitable | 152,503 | 0 | 0 | 0 | For |
| Jackson National | 135,152 | 0 | 0 | 0 | For |
| Transamerica | 134,600 | 0 | 0 | 0 | For |
| American Century | 126,080 | 0 | 0 | 0 | For |
| NYLIM VP FUNDS TRUST | 125,529 | 0 | 0 | 0 | For |
| SEI | 124,761 | 0 | 0 | 0 | For |
| Managed Portfolio Series | 124,478 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 107,580 | 0 | 0 | 0 | For |
Showing the 25 largest of 74 asset managers. All 74 are in the interactive database (link above).
Combines 3 wordings of this item as funds reported it.
99.7% of fund votes cast · no official result
Description as filed by funds: To approve Amendment No. 3 to the Integra LifeSciences Holdings Corporation Fifth Amended and Restated 2003 Equity Incentive Plan.
The 75 asset managers below reported 31,546,011 for, 95,208 against, 19,330 abstained. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 7,098,002 | 0 | 0 | 0 | For |
| Vanguard | 7,027,576 | 3 | 0 | 0 | For |
| Invesco | 3,477,634 | 0 | 0 | 0 | For |
| UNDISCOVERED MANAGERS FUNDS | 2,890,843 | 0 | 0 | 0 | For |
| Charles Schwab | 1,518,669 | 0 | 0 | 0 | For |
| Fidelity | 1,276,394 | 0 | 0 | 0 | For |
| Dimensional | 1,080,614 | 0 | 0 | 0 | For |
| State Street | 994,435 | 57 | 0 | 0 | For |
| GLENMEDE FUND INC | 890,722 | 0 | 0 | 0 | For |
| PARADIGM FUNDS | 710,000 | 0 | 0 | 0 | For |
| PIMCO | 619,001 | 0 | 0 | 0 | For |
| Neuberger Berman | 560,108 | 0 | 0 | 0 | For |
| Hartford | 271,216 | 0 | 0 | 0 | For |
| Victory Capital | 196,094 | 0 | 0 | 0 | For |
| Goldman Sachs | 192,355 | 0 | 0 | 0 | For |
| TRUST FOR PROFESSIONAL MANAGERS | 173,498 | 0 | 0 | 0 | For |
| TIAA | 153,428 | 0 | 0 | 0 | For |
| Equitable | 152,503 | 0 | 0 | 0 | For |
| Jackson National | 135,152 | 0 | 0 | 0 | For |
| Transamerica | 134,600 | 0 | 0 | 0 | For |
| American Century | 126,080 | 0 | 0 | 0 | For |
| NYLIM VP FUNDS TRUST | 125,529 | 0 | 0 | 0 | For |
| SEI | 124,761 | 0 | 0 | 0 | For |
| Managed Portfolio Series | 124,478 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 107,580 | 0 | 0 | 0 | For |
Showing the 25 largest of 75 asset managers. All 75 are in the interactive database (link above).
Combines 8 wordings of this item as funds reported it.
99% Approved · of votes cast
Prior year: 98.2% for (May 9, 2025 meeting) ▲ 0.8 pts
Description as filed by funds: To approve, on a non-binding advisory basis, the compensation of our named executive officers.
Integra LifeSciences Holdings Corporation’s own tally for this item (“3. On an advisory, non-binding basis, the compensation of the Company's named executive officers”): 68,472,769 for, 732,580 against — passed, per its Form 8-K filed May 8, 2026 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Item No. 3: The stockholders approved, on an advisory, non-binding basis, the compensation of the Company's named executive officers, by the votes set forth below.”
Support: 99% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 7,098,002 | 0 | 0 | 0 | For |
| Vanguard | 7,027,577 | 2 | 0 | 0 | For |
| Invesco | 3,477,634 | 0 | 0 | 0 | For |
| UNDISCOVERED MANAGERS FUNDS | 2,890,843 | 0 | 0 | 0 | For |
| Charles Schwab | 1,518,669 | 0 | 0 | 0 | For |
| Fidelity | 1,276,394 | 0 | 0 | 0 | For |
| Dimensional | 1,080,614 | 0 | 0 | 0 | For |
| State Street | 994,435 | 57 | 0 | 0 | For |
| GLENMEDE FUND INC | 890,722 | 0 | 0 | 0 | For |
| PARADIGM FUNDS | 710,000 | 0 | 0 | 0 | For |
| PIMCO | 619,001 | 0 | 0 | 0 | For |
| Neuberger Berman | 560,108 | 0 | 0 | 0 | For |
| Hartford | 271,216 | 0 | 0 | 0 | For |
| Victory Capital | 196,094 | 0 | 0 | 0 | For |
| Goldman Sachs | 192,355 | 0 | 0 | 0 | For |
| TRUST FOR PROFESSIONAL MANAGERS | 173,498 | 0 | 0 | 0 | For |
| TIAA | 153,428 | 0 | 0 | 0 | For |
| Equitable | 152,503 | 0 | 0 | 0 | For |
| Jackson National | 135,152 | 0 | 0 | 0 | For |
| Transamerica | 134,600 | 0 | 0 | 0 | For |
| American Century | 0 | 126,080 | 0 | 0 | Against |
| NYLIM VP FUNDS TRUST | 125,529 | 0 | 0 | 0 | For |
| SEI | 124,761 | 0 | 0 | 0 | For |
| Managed Portfolio Series | 124,478 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 107,580 | 0 | 0 | 0 | For |
Fund voting reports, all 74 managers: 31,447,699 for, 131,742 against, 81,330 abstained. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Rubric Capital Management LP | 3,983,260 | 0 | 0 | 0 | For |
| Invesco | 3,934,408 | 0 | 0 | 0 | For |
| FULLER & THALER ASSET MANAGEMENT, INC. | 3,428,012 | 0 | 0 | 0 | For |
| PARADIGM CAPITAL MANAGEMENT INC/NY | 3,199,820 | 0 | 0 | 0 | For |
| BOSTON MANAGEMENT & RESEARCH | 2,741,345 | 0 | 0 | 0 | For |
| BlackRock | 2,671,694 | 0 | 0 | 0 | For |
| State Street | 2,268,760 | 14,748 | 0 | 0 | For |
| Neuberger Berman | 1,651,082 | 0 | 0 | 0 | For |
| Charles Schwab | 1,563,311 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 1,481,436 | 0 | 0 | 0 | For |
| Wellington | 1,201,933 | 0 | 0 | 0 | For |
| Invenomic Capital Management LP | 966,958 | 0 | 0 | 0 | For |
| Vanguard | 631,699 | 0 | 0 | 0 | For |
| Northern Trust | 560,431 | 3,452 | 0 | 0 | For |
| SYSTEMATIC FINANCIAL MANAGEMENT LP | 531,673 | 0 | 0 | 0 | For |
| CANADA PENSION PLAN INVESTMENT BOARD | 434,900 | 0 | 0 | 0 | For |
| PRINCIPAL GLOBAL INVESTORS | 328,842 | 0 | 0 | 0 | For |
| Leeward Investments, LLC - MA | 294,645 | 0 | 0 | 0 | For |
| Goldman Sachs | 274,558 | 0 | 0 | 0 | For |
| MELLON INVESTMENTS Corp | 264,843 | 0 | 0 | 0 | For |
| Legal & General Investment Management Ltd | 0 | 237,766 | 0 | 0 | Against |
| Eaton Vance | 225,275 | 0 | 0 | 0 | For |
| PUBLIC SECTOR PENSION INVESTMENT BOARD | 219,979 | 0 | 0 | 0 | For |
| PACIFIC INVESTMENT MANAGEMENT CO LLC | 219,703 | 0 | 0 | 0 | For |
| Victory Capital | 198,231 | 0 | 0 | 0 | For |
Institutional-manager reports, all 201 managers: 36,511,984 for, 542,608 against. Showing the 25 largest; every one is in the interactive database (link above).
Combines 4 wordings of this item as funds reported it.
99% Approved · of votes cast
Prior year: 98.7% for (May 9, 2025 meeting) ▲ 0.1 pts
Description as filed by funds: To ratify the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year 2026.
Integra LifeSciences Holdings Corporation’s own tally for this item (“2. The appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the 2026 fiscal year”): 72,313,820 for, 863,179 against — passed, per its Form 8-K filed May 8, 2026 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Item No. 2: The stockholders ratified the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the 2026 fiscal year, by the votes set forth below.”
Support: 99% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 74 asset managers below reported 31,622,552 for, 56,889 against, 19,330 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 7,098,002 | 0 | 0 | 0 | For |
| Vanguard | 7,022,915 | 4,664 | 0 | 0 | For |
| Invesco | 3,477,634 | 0 | 0 | 0 | For |
| UNDISCOVERED MANAGERS FUNDS | 2,890,843 | 0 | 0 | 0 | For |
| Charles Schwab | 1,518,669 | 0 | 0 | 0 | For |
| Fidelity | 1,276,394 | 0 | 0 | 0 | For |
| Dimensional | 1,080,614 | 0 | 0 | 0 | For |
| State Street | 994,435 | 57 | 0 | 0 | For |
| GLENMEDE FUND INC | 890,722 | 0 | 0 | 0 | For |
| PARADIGM FUNDS | 710,000 | 0 | 0 | 0 | For |
| PIMCO | 619,001 | 0 | 0 | 0 | For |
| Neuberger Berman | 560,108 | 0 | 0 | 0 | For |
| Hartford | 271,216 | 0 | 0 | 0 | For |
| Victory Capital | 196,094 | 0 | 0 | 0 | For |
| Goldman Sachs | 192,355 | 0 | 0 | 0 | For |
| TRUST FOR PROFESSIONAL MANAGERS | 173,498 | 0 | 0 | 0 | For |
| TIAA | 153,428 | 0 | 0 | 0 | For |
| Equitable | 152,503 | 0 | 0 | 0 | For |
| Jackson National | 135,152 | 0 | 0 | 0 | For |
| Transamerica | 134,600 | 0 | 0 | 0 | For |
| American Century | 126,080 | 0 | 0 | 0 | For |
| NYLIM VP FUNDS TRUST | 125,529 | 0 | 0 | 0 | For |
| SEI | 124,761 | 0 | 0 | 0 | For |
| Managed Portfolio Series | 124,478 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 107,580 | 0 | 0 | 0 | For |
Showing the 25 largest of 74 asset managers. All 74 are in the interactive database (link above).
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 77,796,903 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | BlackRock | 9.12% |
| 2 | Vanguard | 9.03% |
| 3 | Invesco | 4.47% |
| 4 | UNDISCOVERED MANAGERS FUNDS | 3.72% |
| 5 | Charles Schwab | 1.95% |
| 6 | Fidelity | 1.64% |
| 7 | Dimensional | 1.39% |
| 8 | State Street | 1.28% |
| 9 | GLENMEDE FUND INC | 1.14% |
| 10 | PARADIGM FUNDS | 0.91% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Rubric Capital Management LP | 5.12% |
| 2 | Invesco | 5.06% |
| 3 | FULLER & THALER ASSET MANAGEMENT, INC. | 4.41% |
| 4 | PARADIGM CAPITAL MANAGEMENT INC/NY | 4.11% |
| 5 | BOSTON MANAGEMENT & RESEARCH | 3.52% |
| 6 | BlackRock | 3.43% |
| 7 | State Street | 2.94% |
| 8 | Neuberger Berman | 2.12% |
| 9 | Charles Schwab | 2.01% |
| 10 | GEODE CAPITAL MANAGEMENT, LLC | 1.90% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row gives its source and the date its figure is as of: for Form 13F the quarter end it reports, for Schedules 13D and 13G the filing date, and for the proxy statement the date of its ownership table (or, where that date has not been read, the date the proxy was filed). The rows are therefore not all as of the same day.
| Holder | Shares | % outstanding | Source, as of |
|---|---|---|---|
| BlackRock | 10,319,169 | 13.26% | Form 13F, quarter ended March 31, 2026 |
| Tru St Partnership LP and Provco Leasing Corporation | 8,515,930 | 10.95% | Proxy statement (DEF 14A), proxy filed April 6, 2026 |
| Rubric Capital Management LP | 7,353,934 | 9.45% | Proxy statement (DEF 14A), proxy filed April 6, 2026 |
| Vanguard Group | 7,210,624 | 9.27% | Form 13F, quarter ended March 31, 2026 |
| Morgan Stanley | 3,849,067 | 4.95% | Form 13F, quarter ended March 31, 2026 |
| Invesco | 3,485,603 | 4.48% | Form 13F, quarter ended March 31, 2026 |
| State Street | 2,886,556 | 3.71% | Form 13F, quarter ended March 31, 2026 |
| Dimensional Fund Advisors | 2,774,988 | 3.57% | Form 13F, quarter ended March 31, 2026 |
| Goldman Sachs | 1,876,750 | 2.41% | Form 13F, quarter ended March 31, 2026 |
| Stuart M. Essig, Ph.D. | 1,785,271 | 2.29% | Proxy statement (DEF 14A), proxy filed April 6, 2026 |
Percentages above are of 77,796,903 shares outstanding, as reported by Integra LifeSciences Holdings Corporation on its Form 10-Q dated May 4, 2026 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
At Integra LifeSciences Holdings Corporation's shareholder meeting held May 7, 2026, in the 2025-2026 proxy season, 256 asset managers reported votes on at least one item in their SEC Form N-PX filings, covering 2,835 separate fund positions. Their filings are grouped here into 10 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — To approve, on a non-binding advisory basis, the compensation of our named executive officers. — Integra LifeSciences Holdings Corporation's filing reports the proposal as approved, with 99% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: Integra LifeSciences Holdings Corporation's Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on May 8, 2026.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from Integra LifeSciences Holdings Corporation’s 10-Q dated May 4, 2026. This page is a static snapshot rebuilt weekly on November 20, 2026; a live search always shows the current data.
Integra LifeSciences Holdings Corporation proxy season coverage: 2023-2024 · 2024-2025 · 2025-2026 (this page).
Proxy Votes Now, “Integra LifeSciences Holdings (IART) 2026 Annual Meeting: Vote Results”, https://proxyvotesnow.com/company/integra-lifesciences-holdings-corp/2026 (version of November 20, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.